CCR

CC chemokine receptor (CCR) antagonists block G protein-coupled receptors that guide leukocyte migration. CCR2, a receptor for monocyte chemoattractant protein 1 (MCP-1), was cloned in 1994 as two splice variants. CCR5 was identified in 1996 as a fusion cofactor for macrophage-tropic human immunodeficiency virus type 1 (HIV-1). Maraviroc, described in 2005 as a selective small-molecule CCR5 inhibitor, blocks this route of viral entry. Other CCR5 antagonists include vicriviroc malate and aplaviroc, while INCB3344 and MK-0812 target CCR2. Cenicriviroc blocks both CCR2 and CCR5, and GSK2239633A is a CCR4 antagonist for studies of T cell trafficking.

7 Items

  • NSC5844
    Cat. No.
    A15924

    NSC5844

    Synonyms: RE640

    NSC5844 is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.

    5 mg
    $25.00
    10 mg
    $45.00
    All 6 sizes
  • ZK-756326 dihydrochloride
    Cat. No.
    A16363

    ZK-756326 dihydrochloride

    ZK-756326 is a potent, selective and non-peptide CCR8 chemokine receptor agonist. ZK 756326 inhibited the binding of the CCR8 ligand I-309 (CCL1), with an IC(50) value of 1.8 μM.

    5 mg
    $55.00
    10 mg
    $75.00
    All 5 sizes
  • ZK 756326
    Cat. No.
    A16791

    ZK 756326

    ZK 756326 is a nonpeptide agonist specifically targeting the CC chemokine receptor CCR8. It exhibits potent activity in modulating chemokine signaling pathways, making it a valuable tool in studies related to immune response and inflammation. This compound is useful for researchers investigating the role of CCR8 in various biological processes and potential therapeutic applications.

    2 mg
    $30.00
    5 mg
    $40.00
    All 7 sizes
  • LMD-009
    Cat. No.
    A18643

    LMD-009

    LMD-009 is a selective CCR8 nonpeptide agonist. LMD-009 mediates chemotaxis, inositol phosphate accumulation, and calcium release in high potencies with EC50s from 11 to 87 nM.

    5 mg
    $345.00
    10 mg
    $645.00
    All 5 sizes
  • LMD-902
    Cat. No.
    A59553

    LMD-902

    LMD-902 is a potent CCR8 agonist with an EC50 of 15 nM, demonstrating enhanced binding capacity influenced by critical residues such as PheVI:16. This compound is instrumental in researching inflammatory diseases, including bronchial asthma, as well as central nervous system disorders such as multiple sclerosis. Its specificity and efficacy make LMD-902 a valuable tool for advancing understanding in these therapeutic areas.

    Out of stock

    All 3 sizes
  • CH0076989
    Cat. No.
    A59570

    CH0076989

    CH0076989 is a selective agonist of the CCR3 receptor that activates eosinophils and transfectants expressing both wild-type CCR3 and a CCR1:CCR3 chimeric receptor lacking the CCR3 amino-terminus. This compound exhibits a direct interaction with the transmembrane helices of CCR3; activity is abolished by mutations of key residues Y41, Y113, and E287. CH0076989 is ideal for research into inflammation and allergic diseases, including asthma, making it a valuable tool for understanding these pathological conditions.

    25 mg
    $1,530.00
    All 1 sizes
  • LMD-584
    Cat. No.
    A59583

    LMD-584

    LMD-584 is a selective agonist of CCR8, a chemokine receptor involved in immune responses and inflammation. This compound demonstrates significant biological activity in modulating CCR8 signaling pathways, making it a valuable tool for research applications focused on immune cell trafficking and related pathologies. LMD-584 may aid in understanding the role of CCR8 in various diseases, including cancer and autoimmune disorders.

    Out of stock

    All 3 sizes

7 Items

Added to your cart

View Cart Checkout

    Loading...